|
Volumn 63, Issue 1, 2001, Pages 28-33
|
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
|
Author keywords
Aspirin; Celecoxib; Cyclooxygenase 2; Myocardial infarction; NCX 4016; Nitric oxide; Prostaglandin
|
Indexed keywords
ACETYLSALICYLIC ACID;
ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
NITRIC OXIDE SYNTHASE;
PROSTACYCLIN;
THROMBOXANE A2;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
ENZYME ACTIVATION;
ENZYME SYNTHESIS;
HEART INFARCTION;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS;
RABBIT;
6-KETOPROSTAGLANDIN F1 ALPHA;
ANIMALS;
ASPIRIN;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
EPOPROSTENOL;
HEART;
ISOENZYMES;
MALE;
MYOCARDIAL INFARCTION;
MYOCARDIUM;
NITRIC OXIDE;
NITRIC OXIDE DONORS;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
PLATELET AGGREGATION INHIBITORS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
RABBITS;
SULFONAMIDES;
THROMBOXANE A2;
|
EID: 0034943127
PISSN: 00317012
EISSN: None
Source Type: Journal
DOI: 10.1159/000056109 Document Type: Article |
Times cited : (9)
|
References (19)
|